Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Multicenter Phase 3 Study of Milademetan Versus Trabectedin in Patients With Dedifferentiated Liposarcoma

NCT04979442 is registered in ClinicalTrials.gov with Rain Oncology Inc as lead sponsor.

NCT NCT04979442
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04979442 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Multicenter Phase 3 Study of Milademetan Versus Trabectedin in Patients With Dedifferentiated Liposarcoma
Lead sponsor
Rain Oncology Inc
Phase
Phase 3
Overall status
Terminated
Start date
July 14, 2021
Completion date
October 1, 2023
Enrollment
175 (actual)
Sites
71

Conditions

As the registry lists them; a condition with its own page is linked.

dedifferentiated liposarcoma